Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 2Phase NA 1Phase 4 1

Status

Unknown 9Completed 7Withdrawn 3Recruiting 3Active not recruiting 3Not yet recruiting 2Enrolling by invitation 1

Sponsor Class

OTHER 7INDUSTRY 1

Study Type

Interventional 7

Sponsor

Cancer Type

Lymphoid 7

Conditions

Lymphoma, Large B-Cell, Diffuse 4Lymphoma, Mantle-Cell 2Lymphoma, Non-Hodgkin 1HIV Infections 1

Interventions

Cyclophosphamide 956Radiotherapy 847Cisplatin 757Gemcitabine 657Carboplatin 603Docetaxel 598Paclitaxel 585Bevacizumab 580Fluorouracil 504Oxaliplatin 458Rituximab 453Surveys and Questionnaires 449Capecitabine 440Dexamethasone 428Doxorubicin 424Etoposide 411Irinotecan 389Cytarabine 376Filgrastim 369pembrolizumab 330Leucovorin 305Nivolumab 296fludarabine phosphate 294Melphalan 288Magnetic Resonance Spectroscopy 281Peripheral Blood Stem Cell Transplantation 279Blood Specimen Collection 279Methotrexate 276Lenalidomide 276Cetuximab 270

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Completed × OTHER × R-CHOP protocol × Clear all
NCT01865110 2025-03-05

R-CHOP + R-HAD vs R-CHOP Followed by Maintenance Lenalidomide + Rituximab vs Rituximab for Older Patients With MCL

The Lymphoma Academic Research Organisation

Phase 3 Completed
623 enrolled
Lymphoid

Lymphoma, Mantle-Cell

NCT02633137 2024-08-30

Sequential Chemotherapy and Lenalidomide Followed by Rituximab and Lenalidomide Maintenance for Untreated Mantle Cell Lymphoma

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
49 enrolled 8 charts
Lymphoid

Lymphoma, Mantle-Cell

NCT02660710 2022-10-28

Rituximab Plus CHOP Chemotherapy for Diffuse Large B-cell Lymphoma

UNC Lineberger Comprehensive Cancer Center

Phase 2 Completed
39 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT02890602 2020-02-20

Erythropoietin for Management of Anemia Caused by Chemotherapy

Kosin University Gospel Hospital

Phase 2 Completed
53 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT00530179 2019-01-22

PET-Chop

AHS Cancer Control Alberta

Phase NA Completed
69 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT00554164 2017-05-05

PETAL

University Hospital, Essen

Phase 3 Completed
1,073 enrolled
Lymphoid

Lymphoma, Non-Hodgkin

NCT00466258 2009-11-25

LINFOTARGAM

PETHEMA Foundation

Phase 4 Completed
50 enrolled
Lymphoid

HIV Infections, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡